MLKL as an emerging machinery for modulating organelle dynamics: regulatory mechanisms, pathophysiological significance, and targeted therapeutics
Frontiers in Pharmacology2025cited by 10position: middledoi
Inhibition of ZFP281/ZNF281–RIPK1/RIPK3/MLKL signaling in hepatocytes by pterostilbene relieves hepatic lipometabolic disorder and inflammation in non-alcoholic steatohepatitis
International Immunopharmacology2024cited by 3position: lastdoi